INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 215 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $156,000 | +4.0% | 16,887 | 0.0% | 0.00% | – |
| Q4 2020 | $150,000 | -23.5% | 16,887 | 0.0% | 0.00% | – |
| Q3 2020 | $196,000 | -78.1% | 16,887 | -49.2% | 0.00% | -100.0% |
| Q2 2020 | $896,000 | +140.9% | 33,237 | -33.5% | 0.00% | 0.0% |
| Q1 2020 | $372,000 | +100.0% | 49,986 | -11.4% | 0.00% | – |
| Q4 2019 | $186,000 | +60.3% | 56,386 | 0.0% | 0.00% | – |
| Q3 2019 | $116,000 | -30.1% | 56,386 | +0.1% | 0.00% | – |
| Q2 2019 | $166,000 | +74.7% | 56,336 | +120.1% | 0.00% | – |
| Q1 2019 | $95,000 | -6.9% | 25,600 | 0.0% | 0.00% | – |
| Q4 2018 | $102,000 | -25.0% | 25,600 | -26.3% | 0.00% | – |
| Q2 2018 | $136,000 | -15.5% | 34,718 | +1.8% | 0.00% | – |
| Q1 2018 | $161,000 | +14.2% | 34,118 | 0.0% | 0.00% | – |
| Q4 2017 | $141,000 | +22.6% | 34,118 | +87.8% | 0.00% | – |
| Q3 2017 | $115,000 | – | 18,168 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Round Table Services, LLC | 129,500 | $1,207,000 | 0.72% |
| STONERIDGE INVESTMENT PARTNERS LLC | 252,376 | $2,352,000 | 0.34% |
| Bellevue Group AG | 155,000 | $1,445,000 | 0.26% |
| WASATCH ADVISORS LP | 1,861,553 | $17,350,000 | 0.26% |
| Blue Clay Capital Management, LLC | 13,000 | $121,000 | 0.14% |
| Virtus ETF Advisers LLC | 24,058 | $224,000 | 0.11% |
| EMERALD ADVISERS, LLC | 203,737 | $1,899,000 | 0.08% |
| Vident Investment Advisory, LLC | 63,383 | $591,000 | 0.08% |
| Thomas J. Herzfeld Advisors, Inc. | 15,000 | $140,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 94,400 | $880,000 | 0.05% |